Allakos Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Allakos Stock Summary

Allakos competes with Apellis Pharmaceuticals, Blueprint Medicines, Day One, Atara Biotherapeutics, and Fate Therapeutics. Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company was incorporated in 2012 and is headquartered in Redwood City, California. Allakos operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 192 people.

Allakos Key Financial Ratios

Allakos Key Balance Sheet Accounts

Allakos Key Cash Accounts

Allakos Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Allakos's current stock value. Our valuation model uses many indicators to compare Allakos value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Allakos competition to find correlations between indicators driving Allakos's intrinsic value. More Info.Allakos is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Allakos' Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Allakos by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Allakos Systematic Risk

Today, most investors in Allakos Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Allakos' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Allakos growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Allakos help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Allakos. We use our internally-developed statistical techniques to arrive at the intrinsic value of Allakos based on widely used predictive technical indicators. In general, we focus on analyzing Allakos Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Allakos's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allakos. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Allakos Stock please use our How to buy in Allakos Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allakos. If investors know Allakos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allakos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Allakos is measured differently than its book value, which is the value of Allakos that is recorded on the company's balance sheet. Investors also form their own opinion of Allakos' value that differs from its market value or its book value, called intrinsic value, which is Allakos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allakos' market value can be influenced by many factors that don't directly affect Allakos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Allakos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Allakos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allakos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.